Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.

Du N, Feng J, Hu LJ, Sun X, Sun HB, Zhao Y, Yang YP, Ren H.

Oncol Rep. 2012 Jun;27(6):1893-903. doi: 10.3892/or.2012.1720. Epub 2012 Mar 13.

PMID:
22426690
2.

Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.

Zhao Y, Chen X, Cai L, Yang Y, Sui G, Fu S.

J Cell Physiol. 2010 Oct;225(1):168-73. doi: 10.1002/jcp.22209.

PMID:
20458733
3.

Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.

Ager EI, Wen SW, Chan J, Chong WW, Neo JH, Christophi C.

BMC Cancer. 2011 Jun 26;11:274. doi: 10.1186/1471-2407-11-274.

5.

Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.

Zhao Y, Wang H, Li X, Cao M, Lu H, Meng Q, Pang H, Li H, Nadolny C, Dong X, Cai L.

J Cell Physiol. 2014 Nov;229(11):1855-62. doi: 10.1002/jcp.24639.

PMID:
24692224
6.

Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein.

Li W, Liu J, Hammond SL, Tjalkens RB, Saifudeen Z, Feng Y.

Am J Physiol Regul Integr Comp Physiol. 2015 Jul 15;309(2):R138-47. doi: 10.1152/ajpregu.00319.2014. Epub 2015 May 20.

7.

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.

Coulson R, Liew SH, Connelly AA, Yee NS, Deb S, Kumar B, Vargas AC, O'Toole SA, Parslow AC, Poh A, Putoczki T, Morrow RJ, Alorro M, Lazarus KA, Yeap EFW, Walton KL, Harrison CA, Hannan NJ, George AJ, Clyne CD, Ernst M, Allen AM, Chand AL.

Oncotarget. 2017 Mar 21;8(12):18640-18656. doi: 10.18632/oncotarget.15553.

8.

NF-κB and CREB are required for angiotensin II type 1 receptor upregulation in neurons.

Haack KK, Mitra AK, Zucker IH.

PLoS One. 2013 Nov 11;8(11):e78695. doi: 10.1371/journal.pone.0078695. eCollection 2013.

9.

Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis.

Mizushima T, Sasaki M, Ando T, Wada T, Tanaka M, Okamoto Y, Ebi M, Hirata Y, Murakami K, Mizoshita T, Shimura T, Kubota E, Ogasawara N, Tanida S, Kataoka H, Kamiya T, Alexander JS, Joh T.

Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G255-66. doi: 10.1152/ajpgi.00264.2009. Epub 2009 Nov 25.

10.

Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.

Kinoshita J, Fushida S, Harada S, Yagi Y, Fujita H, Kinami S, Ninomiya I, Fujimura T, Kayahara M, Yashiro M, Hirakawa K, Ohta T.

Int J Oncol. 2009 Jun;34(6):1573-82.

PMID:
19424575
11.

Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.

Azuma K, Tamura K, Shigenaga A, Wakui H, Masuda S, Tsurumi-Ikeya Y, Tanaka Y, Sakai M, Matsuda M, Hashimoto T, Ishigami T, Lopez-Ilasaca M, Umemura S.

Hypertension. 2007 Nov;50(5):926-32. Epub 2007 Sep 17.

13.

Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.

Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y, Tsubota K, Okano H, Oike Y, Ishida S.

Diabetes. 2008 Aug;57(8):2191-8. doi: 10.2337/db07-1281. Epub 2008 May 16.

14.

β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.

Wang Y, Huang J, Liu X, Niu Y, Zhao L, Yu Y, Zhou L, Lu L, Yu C.

Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F1-F8. doi: 10.1152/ajprenal.00588.2016. Epub 2017 Mar 8.

PMID:
28274926
16.

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.

Chen X, Meng Q, Zhao Y, Liu M, Li D, Yang Y, Sun L, Sui G, Cai L, Dong X.

Cancer Lett. 2013 Jan 28;328(2):318-24. doi: 10.1016/j.canlet.2012.10.006. Epub 2012 Oct 22.

PMID:
23092556
17.

PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.

Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thöne-Reineke C, Unger T, Kintscher U.

Hypertension. 2005 Jul;46(1):137-43. Epub 2005 Jun 6.

18.

Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.

Hasan AU, Ohmori K, Hashimoto T, Kamitori K, Yamaguchi F, Ishihara Y, Ishihara N, Noma T, Tokuda M, Kohno M.

Hypertens Res. 2014 Jul;37(7):621-8. doi: 10.1038/hr.2014.51. Epub 2014 Mar 6.

PMID:
24599011
19.
20.

Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders.

Maeda A, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Kanaoka T, Dejima T, Ohki K, Haku S, Yamashita A, Umemura S.

Int J Med Sci. 2014 Apr 27;11(6):646-51. doi: 10.7150/ijms.8577. eCollection 2014.

Supplemental Content

Support Center